BIO

Konstantin Matentzoglu is the Delegated Supervisory Board Member of Polpharma Biologics Group and a seasoned leader in biotechnology.

Throughout his career, he has led significant growth transformations in the life sciences sector.

He also serves on the boards of BSP Pharmaceuticals S.p.A. in Latina, Italy; Prediction Biosciences SAS in Lyon, France; and CDL Therapeutics GmbH in Cologne, Germany.

Formerly, he was CEO and Board Member of Celonic Group.

Konstantin earned his graduate degree in Biology from the University of Cologne, spent three years at the Netherlands Cancer Institute, and holds a PhD from the University of Constance.